• Advance from reactive to proactive care with accessible, system-wide high-risk patient identification
• Standardize guideline-based risk assessments for hereditary cancer testing and breast cancer risk to enable more equitable access to early diagnosis and prevention
• Discuss real-world barriers and strategies for scaling high-risk cancer identification programs